Discngine, a software company specializing in applications for life sciences research, today announces a Series A financing round of €1.1 million ($1.3M), received from Extens Développement e-Santé. The funds raised will allow Discngine to move forward with its Software-as-a-Service (SaaS) solution offering for the life sciences industry, a model that is not, as yet, widely used in this sector.

The developers of a communication platform that offers secure digital access to healthcare services have received £200,000 of seed funding in a deal led by Mercia Fund Management and involving the NHS-backed West Midlands Academic Health Science Networks (AHSNs) fund.

Footfalls & Heartbeats today announce a strategic investment round of £1.25m with The Enterprise Investment Scheme (EIS) tax relief. New product innovation is a key area of focus for Footfalls & Heartbeats, whose wearable technology is providing personalised, preventative healthcare, and solutions to aid the wellbeing of individuals.

Pharmacy2u.co.uk, the UK’s leading NHS approved online only pharmacy, has secured a further £7m of investment from BGF (Business Growth Fund) and other shareholders to continue to support the rapid growth of its home delivery repeat prescriptions service for NHS patients.

Vyaire Medical, the healthcare industry's largest pure-play "breathing" company, announced it has acquired Ciel Medical, a medical device company focused on solving unmet needs of medical professionals caring for intubated patients.